It is a broadly described annual report of Beacon Pharmaceuticals Limited in the year of 2016. Cost of Goods Sold for the year stands at Taka. 1,292,608,372.00 which is 21.76% higher than that of the previous year. During the financial year, The Company’s Gross Profit Taka. 1,199,196,063 million. Operating Profit Taka. 264,093,190 million. Net Profit after tax for the year Taka. 61,402,978 million.
The Board of Directors of the Company has recommended @5% cash dividend for the year ended 30th June 2016. These financial statements are presented in Bangladesh Taka (Taka/Tk/BDT) which is the company’s functional currency. All financial information presented in Taka has been rounded off to the nearest Taka.
More Annual Report of Beacon Pharmaceuticals Limited:
- Annual Report 2010 of Beacon Pharmaceuticals Limited
- Annual Report 2012 of Beacon Pharmaceuticals Limited
- Annual Report 2013 of Beacon Pharmaceuticals Limited
- Annual Report 2014 of Beacon Pharmaceuticals Limited
- Annual Report 2015 of Beacon Pharmaceuticals Limited
- Annual Report 2016 of Beacon Pharmaceuticals Limited
